Uri-K (1500 mg+250 mg)/5 ml (Oral Solution)

Title

• Uri-K Oral Solution

Categories

• Medicine
• OTC Medication
• Urinary Tract Health

Description

• Uri-K is a stable and pleasant-tasting oral systemic alkalizer indicated for relieving discomfort in urinary tract infections, preventing kidney stone formation, preventing gout with a uricosuric agent, and treating acidosis caused by kidney diseases.

Color Options

• Clear liquid

Function

• Relieves discomfort in urinary tract infections
• Prevents kidney stone
• Prevents gout with uricosuric agent
• Treats acidosis caused by kidney diseases

Ingredients

• Potassium Citrate
• Citric Acid

Dosage & Administration

• Adult dosage: 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water
• Pediatric dosage: 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water
• Can be diluted with specified amounts of water for different age groups

Administration Method

• Oral ingestion

Interactions

• Concurrent administration of potassium-containing medication, potassium-sparing diuretics, ACE inhibitors, or cardiac glycosides may lead to toxicity

Contraindications

• Severe renal impairment with oliguria or azotemia
• Untreated Addison's disease
• Acute dehydration
• Severe myocardial damage
• Hyperkalemia from any cause

Side Effects

• Potential side effects include listlessness, weakness, mental confusion, tingling of extremities, and other symptoms associated with high serum Potassium levels
• Caution required in patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis

Pregnancy & Lactation

• No information available regarding use during pregnancy and lactation

Precautions & Warnings

• Use with caution in patients with low urinary output
• Dilute adequately with water to minimize gastrointestinal injury
• Preferably take each dose after meals
• Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease

Overdose Effects

• Oral Potassium salts rarely cause serious hyperkalemia in persons with normal excretory mechanisms
• If hyperkalemia occurs, immediate treatment measures include elimination of potassium-containing foods or medications, intravenous administration of dextrose solution, and use of exchange resins, hemodialysis, or peritoneal dialysis

Therapeutic Class

• Prevention of repeated kidney stone formation
• Urinary Alkalinizing Agent

Storage Conditions

• Keep below 30°C away from light and moisture, out of the reach of children

Related Brands

• Alcasol (1500 mg+250 mg)/5 ml (Oral Solution) - aci-limited